Atlas Trials

Study of FibroGen (FG)-3019 in Subjects With Type 2 Diabetes Mellitus and Kidney Disease on ACEi and/or ARB Therapy

Clinical trial NCT00913393 · TERMINATED

Trial details

NCT number
NCT00913393
Sponsor
Kyntra Bio
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Type 2 Diabetes MellitusDiabetic NephropathyDiabetic Kidney Disease
Start date
2009-02-01
Primary completion
2010-06-01
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.